Guardian Pharmacy Services (GRDN) Shares Outstanding (Weighted Average) (2024 - 2026)

Guardian Pharmacy Services has disclosed Shares Outstanding (Weighted Average) across 3 years of filings, most recently posting $63321.0 for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $63321.0, up 21.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $63321.0 (up 21.17% YoY), and the FY2025 annual result was $62.4 million, up 580.89% from the prior year.
• Shares Outstanding (Weighted Average) came in at $63321.0 for Q1 2026 at Guardian Pharmacy Services, down from $62.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $62.4 million in Q4 2025 to a low of $52256.0 in Q1 2025.
• The 3-year median for Shares Outstanding (Weighted Average) is $9.2 million (2024), against an average of $17.9 million.
• Across the five-year window, Shares Outstanding (Weighted Average) jumped 580.89% in 2025 and grew 21.17% in 2026, its largest moves.
• Guardian Pharmacy Services' Shares Outstanding (Weighted Average) stood at $9.2 million in 2024, then surged by 580.89% to $62.4 million in 2025, then slumped by 99.9% to $63321.0 in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $63321.0 (Q1 2026), $62.4 million (Q4 2025), and $23.0 million (Q3 2025), per Business Quant data.